Ceritinib D7 is a deuterium-labeled active pharmaceutical ingredient used in research and pharmaceutical manufacturing. It is a chemical compound with a complex structure containing amine, ether, and halogen functional groups, designed for analytical and developmental studies.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1632484-77-5
Sitafloxacin
active pharmaceutical ingredient
((plusmn))-Zanubrutinib
active pharmaceutical ingredient
(3R,4S)-1-(4-Fluorophenyl)-3-[(3R)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone
active pharmaceutical ingredient
Teriflunomide
active pharmaceutical ingredient
Ceritinib
active pharmaceutical ingredient
5-chloro-2-N-[2-(1,1,1,2,3,3,3-heptadeuteriopropan-2-yloxy)-5-methyl-4-piperidin-4-ylphenyl]-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine
VERWOWGGCGHDQE-WFBMWZOZSA-N
[2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])OC1=C(C=C(C(=C1)C2CCNCC2)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl